Á lódáil...
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data
To treat hypertension, combining two or more antihypertensive drugs from different classes is often necessary. β-Blockers and renin–angiotensin–aldosterone system inhibitors, when combined, have been deemed ‘less effective’ based on partially overlapping mechanisms of action and limited evidence. Re...
Na minha lista:
| Foilsithe in: | J Hypertens |
|---|---|
| Main Authors: | , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Lippincott Williams & Wilkins
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5548499/ https://ncbi.nlm.nih.gov/pubmed/28509722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HJH.0000000000001412 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|